PMC:7212965 / 43436-43737 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T100","span":{"begin":30,"end":35},"obj":"Body_part"}],"attributes":[{"id":"A100","pred":"fma_id","subj":"T100","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":" avoided when possible. Acute liver failure, although reported, is rare. Ritonavir has potent effects on cytochrome P450 and therefore affects drug levels of a large number of medications typically given in GI practices.\n\nFavipiravir\nThere are 2 published studies on favipiravir in COVID-19. The first"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T76","span":{"begin":30,"end":35},"obj":"Body_part"}],"attributes":[{"id":"A76","pred":"uberon_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":" avoided when possible. Acute liver failure, although reported, is rare. Ritonavir has potent effects on cytochrome P450 and therefore affects drug levels of a large number of medications typically given in GI practices.\n\nFavipiravir\nThere are 2 published studies on favipiravir in COVID-19. The first"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T225","span":{"begin":24,"end":43},"obj":"Disease"},{"id":"T226","span":{"begin":282,"end":290},"obj":"Disease"}],"attributes":[{"id":"A225","pred":"mondo_id","subj":"T225","obj":"http://purl.obolibrary.org/obo/MONDO_0019542"},{"id":"A226","pred":"mondo_id","subj":"T226","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" avoided when possible. Acute liver failure, although reported, is rare. Ritonavir has potent effects on cytochrome P450 and therefore affects drug levels of a large number of medications typically given in GI practices.\n\nFavipiravir\nThere are 2 published studies on favipiravir in COVID-19. The first"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T326","span":{"begin":30,"end":35},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T327","span":{"begin":30,"end":35},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T328","span":{"begin":83,"end":86},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T329","span":{"begin":158,"end":159},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" avoided when possible. Acute liver failure, although reported, is rare. Ritonavir has potent effects on cytochrome P450 and therefore affects drug levels of a large number of medications typically given in GI practices.\n\nFavipiravir\nThere are 2 published studies on favipiravir in COVID-19. The first"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T104","span":{"begin":105,"end":120},"obj":"Chemical"},{"id":"T105","span":{"begin":105,"end":115},"obj":"Chemical"},{"id":"T106","span":{"begin":143,"end":147},"obj":"Chemical"},{"id":"T107","span":{"begin":207,"end":209},"obj":"Chemical"},{"id":"T108","span":{"begin":267,"end":278},"obj":"Chemical"}],"attributes":[{"id":"A104","pred":"chebi_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/CHEBI_38559"},{"id":"A105","pred":"chebi_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/CHEBI_4056"},{"id":"A106","pred":"chebi_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A107","pred":"chebi_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"},{"id":"A108","pred":"chebi_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"}],"text":" avoided when possible. Acute liver failure, although reported, is rare. Ritonavir has potent effects on cytochrome P450 and therefore affects drug levels of a large number of medications typically given in GI practices.\n\nFavipiravir\nThere are 2 published studies on favipiravir in COVID-19. The first"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T200","span":{"begin":24,"end":43},"obj":"Phenotype"}],"attributes":[{"id":"A200","pred":"hp_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/HP_0006554"}],"text":" avoided when possible. Acute liver failure, although reported, is rare. Ritonavir has potent effects on cytochrome P450 and therefore affects drug levels of a large number of medications typically given in GI practices.\n\nFavipiravir\nThere are 2 published studies on favipiravir in COVID-19. The first"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T13","span":{"begin":105,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0045158"},{"id":"T14","span":{"begin":105,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0045157"},{"id":"T15","span":{"begin":105,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0045156"},{"id":"T16","span":{"begin":105,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0008121"}],"text":" avoided when possible. Acute liver failure, although reported, is rare. Ritonavir has potent effects on cytochrome P450 and therefore affects drug levels of a large number of medications typically given in GI practices.\n\nFavipiravir\nThere are 2 published studies on favipiravir in COVID-19. The first"}

{"project":"LitCovid-sentences","denotations":[{"id":"T290","span":{"begin":24,"end":72},"obj":"Sentence"},{"id":"T291","span":{"begin":73,"end":220},"obj":"Sentence"},{"id":"T292","span":{"begin":222,"end":233},"obj":"Sentence"},{"id":"T293","span":{"begin":234,"end":291},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" avoided when possible. Acute liver failure, although reported, is rare. Ritonavir has potent effects on cytochrome P450 and therefore affects drug levels of a large number of medications typically given in GI practices.\n\nFavipiravir\nThere are 2 published studies on favipiravir in COVID-19. The first"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1178","span":{"begin":105,"end":120},"obj":"Gene"},{"id":"1179","span":{"begin":207,"end":209},"obj":"Gene"},{"id":"1182","span":{"begin":73,"end":82},"obj":"Chemical"},{"id":"1189","span":{"begin":24,"end":43},"obj":"Disease"},{"id":"1191","span":{"begin":222,"end":233},"obj":"Chemical"},{"id":"1205","span":{"begin":267,"end":278},"obj":"Chemical"},{"id":"1211","span":{"begin":282,"end":290},"obj":"Disease"}],"attributes":[{"id":"A1178","pred":"tao:has_database_id","subj":"1178","obj":"Gene:4051"},{"id":"A1179","pred":"tao:has_database_id","subj":"1179","obj":"Gene:2770"},{"id":"A1182","pred":"tao:has_database_id","subj":"1182","obj":"MESH:D019438"},{"id":"A1189","pred":"tao:has_database_id","subj":"1189","obj":"MESH:D017114"},{"id":"A1191","pred":"tao:has_database_id","subj":"1191","obj":"MESH:C462182"},{"id":"A1205","pred":"tao:has_database_id","subj":"1205","obj":"MESH:C462182"},{"id":"A1211","pred":"tao:has_database_id","subj":"1211","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" avoided when possible. Acute liver failure, although reported, is rare. Ritonavir has potent effects on cytochrome P450 and therefore affects drug levels of a large number of medications typically given in GI practices.\n\nFavipiravir\nThere are 2 published studies on favipiravir in COVID-19. The first"}